---
title: "Board Evaluation Review of Medicines and Healthcare products Regulatory Agency"
ocid: "ocds-h6vhtk-06f309"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06f309"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06f309.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06f309.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "Medicines and Healthcare Products Regulatory Agency"
published: "2026-09-07"
---

# Board Evaluation Review of Medicines and Healthcare products Regulatory Agency

Buyer: Medicines and Healthcare Products Regulatory Agency  
Current stage: Award  
OCID: ocds-h6vhtk-06f309

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06f309)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06f309.json)

## Summary

MHRA commissioned an external review of the effectiveness of its board. The requirement is a business and management consultancy service focused on evaluating board performance and effectiveness. MHRA is the Medicines and Healthcare products Regulatory Agency, a central government public authority based in London, and the work concerns its own board. The procurement is categorised as consultancy and related business management services. The requirement was treated as a single service package rather than being divided into separate areas of work. This suits consultancies that provide independent board evaluations, governance reviews, organisational effectiveness assessments or related advice to public bodies. The work is for MHRA’s organisational governance and board oversight, rather than for the regulation, manufacture or supply of medicines and healthcare products.

The procurement is complete and was awarded through a direct, below-threshold procedure without competition. Praesta Partners LLP was selected as the supplier and the award is active. The contract was signed on 31 August 2026, with delivery running from 1 September 2026 to 31 December 2026. Its value is £35,000 excluding VAT and £42,000 including VAT. The award covered the full single lot for the board evaluation review. The published evaluation basis was therefore the buyer’s direct-award route rather than a competitive scoring exercise. This outcome shows MHRA used a short, focused commissioning route for a defined external review, with the supplier appointed for the complete requirement.

For a consultancy competing for similar work, the award indicates demand for an independent specialist able to assess the effectiveness of a central government agency board and produce a focused governance review. Relevant capability would include board evaluation methodology, public-sector governance, assessment of board effectiveness, evidence-based interviewing or review work, and clear reporting for senior decision-makers. Experience with regulators, government departments or other complex public bodies would help a supplier understand accountability, assurance and the public-interest context. The selected supplier is an SME, showing that this requirement can be delivered by a focused specialist consultancy rather than only by a large professional-services firm. A credible competitor would need to demonstrate senior expertise, independence, discretion and the capacity to complete a contained review to a public-sector standard.

## Notice

External review of the effectiveness of Medicines and Healthcare products Regulatory Agency's board.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/084197-2026 |
| Notice type | UK7 - Contract Details Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Direct |
| Procurement method details | Below threshold - without competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 7 Sep 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 1 Sep 2026 - 31 Dec 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £35,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | Medicines and Healthcare Products Regulatory Agency |
| Locality | LONDON |
| Postcode area | East London |
| Postcode | E14 4PU |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | Praesta Partners LLP |

## CPV Codes

### Divisions

- 79 - Business services: law, marketing, consulting, recruitment, printing and security

### Codes

- 79400000 - Business and management consultancy and related services

## Release History

- 7 Sep 2026 at 09:19 - Award - UK7 - Contract Details Notice - https://www.find-tender.service.gov.uk/Notice/084197-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/084197-2026
  7th September 2026 - Contract details notice on Find a Tender

## Notice URLs

- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06f309. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06f309.json.